Phesgo: payments to doctors
Payments that named Phesgo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 5,549
- Transactions
- 12,640
- Average per transaction
- $109
The per-transaction average — $109 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,549 providers the average total is $248, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genentech USA, Inc. | $1,372,806 | 99.6% |
| Genentech, Inc. | $4,939 | 0.4% |
| F. Hoffmann-la Roche AG | $15 | 0.0% |